FindMyRecallSubscribe
Class I: serious health riskTerminated

Teva Pharmaceuticals Amikacin Sulfate injection Recall

Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured i…

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class I
Reported by FDA
Jun 1, 2016
Recall ID
D-0859-2016
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Amikacin Sulfate injection starting Mar 9, 2016. The FDA classified it as Class I (serious health risk) and published enforcement report D-0859-2016 on Jun 1, 2016. Reason: Presence of Particulate Matter: particulate matter identified as glass in one vial. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: particulate matter identified as glass in one vial.

Product description

Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454. Individual Pack NDC 0703-9040-01, Shelf Pack NDC 0703-9040-03

Lot numbers, UPCs & expiration codes

Lot #: 4750915, Exp 9/2017

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0859-2016
Classification
Class I
Status
Terminated
Recall initiated
Mar 9, 2016
FDA report date
Jun 1, 2016
Quantity
6,291 units
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0859-2016, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
73455
Address
1090 Horsham Rd
Code information
Lot #: 4750915, Exp 9/2017
Postal code
19454-1505
Report date
Jun 1, 2016
Product type
Drugs
Recall number
D-0859-2016
Classification
Class I
Recalling firm
Teva Pharmaceuticals USA
Product quantity
6,291 units
Termination date
Feb 7, 2017
Reason for recall
Presence of Particulate Matter: particulate matter identified as glass in one vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454. Individual Pack NDC 0703-9040-01, Shelf Pack NDC 0703-9040-03
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Mar 9, 2016
Initial firm notification
Letter
Center classification date
May 23, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0859-2016, published Jun 1, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls